Voluntary Improvement Program (VIP) Becomes the First Case for Quality Program Recognized by the FDA
FDA highlights key opportunities offered by VIP, which leverages ISACA’s Medical Device Discovery Appraisal Program (MDDAP) SCHAUMBURG, Ill.–(BUSINESS WIRE)–The Voluntary Improvement Program (VIP) has become the first Case for Quality program recognized by the United States Food and Drug Administration (FDA) through formal Draft Guidance published 6 May 2022. VIP leverages ISACA’s Medical Device Discovery […]